Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2020 Filed Oct 13, 2020 15:03 UTC |
Goldwasser LesleyDirector
|
GrantCommon Stock | 6,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000248 · wf-form4_160260137481725.xml · nonDerivative · entry 1 Goldwasser Lesley · CIK 0001465575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,585 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 11:07 UTC |
Smith Bradley E.Director
|
GrantCommon Stock | 5,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000252 · wf-form4_160260161010648.xml · nonDerivative · entry 1 Smith Bradley E. · CIK 0001579089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,407 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 11:05 UTC |
Mielle DominiqueDirector
|
GrantCommon Stock | 5,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000250 · wf-form4_160260151670216.xml · nonDerivative · entry 1 Mielle Dominique · CIK 0001759191 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,169 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 11:01 UTC |
Friedman Paul MDirector
|
GrantCommon Stock | 5,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000246 · wf-form4_160260127567821.xml · nonDerivative · entry 1 Friedman Paul M · CIK 0001648181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,410 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 10:41 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,852 | $5.20 | $14,816.14 |
DisclosureSEC source: 0001393726-20-000244 · wf-form4_160260009356217.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,583,754 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.10 to $5.24, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 07, 2020 Filed Oct 8, 2020 11:26 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,852 | $5.09 | $14,508.12 |
DisclosureSEC source: 0001393726-20-000242 · wf-form4_160217075238434.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,580,902 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.98 to $5.12 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 11:26 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,852 | $5.05 | $14,396.90 |
DisclosureSEC source: 0001393726-20-000242 · wf-form4_160217075238434.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,578,050 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.95 to $5.10, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 09:47 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,852 | $4.98 | $14,211.52 |
DisclosureSEC source: 0001393726-20-000240 · wf-form4_160199205757207.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,575,198 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.90 to $5.00 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 09:47 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,803 | $4.92 | $13,776.75 |
DisclosureSEC source: 0001393726-20-000240 · wf-form4_160199205757207.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,572,346 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.82 to $4.94, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 12:05 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,803 | $4.92 | $13,779.55 |
DisclosureSEC source: 0001393726-20-000238 · wf-form4_160165470986166.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,569,543 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.84 to $4.98 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 12:05 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,803 | $4.98 | $13,950.53 |
DisclosureSEC source: 0001393726-20-000238 · wf-form4_160165470986166.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,566,740 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.94 to $5.00, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 29, 2020 Filed Sep 30, 2020 10:01 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,803 | $4.91 | $13,773.94 |
DisclosureSEC source: 0001393726-20-000236 · wf-form4_160147449216945.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,563,937 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.87 to $4.95 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 10:01 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,803 | $5.03 | $14,107.50 |
DisclosureSEC source: 0001393726-20-000236 · wf-form4_160147449216945.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,561,134 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.87 to $5.07, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 25, 2020 Filed Sep 28, 2020 10:26 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,483 | $4.84 | $12,015.24 |
DisclosureSEC source: 0001393726-20-000234 · wf-form4_160130317144682.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,558,331 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.67 to $4.88 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 10:26 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,483 | $4.66 | $11,575.75 |
DisclosureSEC source: 0001393726-20-000234 · wf-form4_160130317144682.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,555,848 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.62 to $4.69, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 23, 2020 Filed Sep 24, 2020 09:54 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,483 | $4.65 | $11,538.50 |
DisclosureSEC source: 0001393726-20-000232 · wf-form4_160095565804862.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,553,365 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.59 to $4.75 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 09:54 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,483 | $4.66 | $11,578.23 |
DisclosureSEC source: 0001393726-20-000232 · wf-form4_160095565804862.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,550,882 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.55 to $4.75, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 21, 2020 Filed Sep 22, 2020 10:07 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 2,483 | $4.95 | $12,278.44 |
DisclosureSEC source: 0001393726-20-000230 · wf-form4_160078364184340.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,548,399 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.85 to $4.99 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 10:07 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,555 | $5.02 | $7,810.77 |
DisclosureSEC source: 0001393726-20-000230 · wf-form4_160078364184340.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,545,916 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.00 to $5.05, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 10:00 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,555 | $5.01 | $7,787.44 |
DisclosureSEC source: 0001393726-20-000228 · wf-form4_160043760147273.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,544,361 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.98 to $5.05 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 16, 2020 Filed Sep 18, 2020 10:00 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,555 | $5.01 | $7,784.33 |
DisclosureSEC source: 0001393726-20-000228 · wf-form4_160043760147273.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,542,806 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.98 to $5.02, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 09:44 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,555 | $5.03 | $7,818.54 |
DisclosureSEC source: 0001393726-20-000226 · wf-form4_160026384325258.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,541,251 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.01 to $5.05 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 09:44 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,555 | $5.06 | $7,866.75 |
DisclosureSEC source: 0001393726-20-000226 · wf-form4_160026384325258.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,539,696 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.02 to $5.11, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 11, 2020 Filed Sep 14, 2020 09:38 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,269 | $5.07 | $6,431.29 |
DisclosureSEC source: 0001393726-20-000224 · wf-form4_160009071771612.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,538,141 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.04 to $5.10 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 09:38 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,269 | $5.12 | $6,497.28 |
DisclosureSEC source: 0001393726-20-000224 · wf-form4_160009071771612.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,536,872 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.08 to $5.15, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 09, 2020 Filed Sep 10, 2020 11:52 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,269 | $5.16 | $6,548.04 |
DisclosureSEC source: 0001393726-20-000222 · wf-form4_159975311395120.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,535,603 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.13 to $5.22 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 11:52 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 1,269 | $5.25 | $6,663.52 |
DisclosureSEC source: 0001393726-20-000222 · wf-form4_159975311395120.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,534,334 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.16 to $5.33, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 09:34 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,732 | $5.39 | $30,866.82 |
DisclosureSEC source: 0001393726-20-000220 · wf-form4_159957204288116.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,533,065 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.33 to $5.41 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 09:34 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,732 | $5.47 | $31,342.58 |
DisclosureSEC source: 0001393726-20-000220 · wf-form4_159957204288116.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,527,333 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.40 to $5.52, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 10:13 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,732 | $5.49 | $31,445.75 |
DisclosureSEC source: 0001393726-20-000218 · wf-form4_159914242393297.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,521,601 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.46 to $5.53 inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 10:13 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,732 | $5.59 | $32,047.61 |
DisclosureSEC source: 0001393726-20-000218 · wf-form4_159914242393297.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,515,869 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.52 to $5.69, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 09:53 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,732 | $5.72 | $32,792.77 |
DisclosureSEC source: 0001393726-20-000216 · wf-form4_159896838457337.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,510,137 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.69 to $5.73, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 28, 2020 Filed Sep 1, 2020 09:53 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,855 | $5.75 | $33,660.40 |
DisclosureSEC source: 0001393726-20-000216 · wf-form4_159896838457337.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,504,405 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.74 to $5.76, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 09:54 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,855 | $5.74 | $33,613.56 |
DisclosureSEC source: 0001393726-20-000211 · wf-form4_159862283457082.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,498,550 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.64 to $5.75, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 09:54 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,855 | $5.62 | $32,910.96 |
DisclosureSEC source: 0001393726-20-000211 · wf-form4_159862283457082.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,492,695 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.54 to $5.65, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 11:13 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,855 | $5.69 | $33,285.68 |
DisclosureSEC source: 0001393726-20-000209 · wf-form4_159845478078901.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,486,840 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.62 to $5.70, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 11:13 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 5,855 | $5.57 | $32,624.06 |
DisclosureSEC source: 0001393726-20-000209 · wf-form4_159845478078901.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,480,985 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.54 to $5.62, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 21, 2020 Filed Aug 24, 2020 13:25 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 4,754 | $5.71 | $27,145.34 |
DisclosureSEC source: 0001393726-20-000207 · wf-form4_159828994585978.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,475,130 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.67 to $5.78, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 13:25 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 4,754 | $5.79 | $27,520.91 |
DisclosureSEC source: 0001393726-20-000207 · wf-form4_159828994585978.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,470,376 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.77 to $5.81, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 09:45 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 4,754 | $5.80 | $27,558.94 |
DisclosureSEC source: 0001393726-20-000205 · wf-form4_159793113598628.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,465,622 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.77 to $5.80, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 09:45 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 4,754 | $5.80 | $27,563.69 |
DisclosureSEC source: 0001393726-20-000205 · wf-form4_159793113598628.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,460,868 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.76 to $5.82, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 14:09 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 4,754 | $5.80 | $27,568.45 |
DisclosureSEC source: 0001393726-20-000203 · wf-form4_159777415278822.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,456,114 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.71 to $5.81, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 14:09 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 4,704 | $5.71 | $26,836.32 |
DisclosureSEC source: 0001393726-20-000203 · wf-form4_159777415278822.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,451,360 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.65 to $5.77, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 11:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 4,704 | $5.79 | $27,222.05 |
DisclosureSEC source: 0001393726-20-000201 · wf-form4_159741892622466.xml · nonDerivative · entry 2 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,446,656 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.71 to $5.87, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 11:28 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 4,704 | $5.91 | $27,795.94 |
DisclosureSEC source: 0001393726-20-000201 · wf-form4_159741892622466.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,441,952 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.85 to $5.96, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 07, 2020 Filed Jul 8, 2020 11:49 UTC |
Barnes Michael GeneDirector · Executive Chairman · 10% owner
|
PurchaseCommon Stock | 342 | $5.83 | $1,993.86 |
DisclosureSEC source: 0001393726-20-000190 · wf-form4_159422332874066.xml · nonDerivative · entry 1 Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,437,248 F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 20:27 UTC |
Goldwasser LesleyDirector
|
GrantCommon Stock | 5,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000182 · wf-form4_159406725175669.xml · nonDerivative · entry 1 Goldwasser Lesley · CIK 0001465575 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,486 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 16:31 UTC |
Mack John EdwardDirector
|
GrantCommon Stock | 4,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000188 · wf-form4_159406748218772.xml · nonDerivative · entry 1 Mack John Edward · CIK 0001381172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,773 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 16:30 UTC |
Friedman Paul MDirector
|
GrantCommon Stock | 4,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000186 · wf-form4_159406740508474.xml · nonDerivative · entry 1 Friedman Paul M · CIK 0001648181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,328 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 16:29 UTC |
Mielle DominiqueDirector
|
GrantCommon Stock | 4,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001393726-20-000184 · wf-form4_159406733553848.xml · nonDerivative · entry 1 Mielle Dominique · CIK 0001759191 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,087 F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.